Lebwohl, M. G., Blauvelt, A., Menter, A., Papp, K. A., Guenthner, S., Pillai, R., . . . Jacobson, A. (2019). Efficacy, Safety, and Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab for 5 Years in a Long-Term, Open-Label, Phase II Study. Am J Clin Dermatol.

Lebwohl, Mark G., Andrew Blauvelt, Alan Menter, Kim A. Papp, Scott Guenthner, Radhakrishnan Pillai, Robert J. Israel, e Abby Jacobson. "Efficacy, Safety, and Patient-Reported Outcomes in Patients With Moderate-to-Severe Plaque Psoriasis Treated With Brodalumab for 5 Years in a Long-Term, Open-Label, Phase II Study." Am J Clin Dermatol 2019.

Lebwohl, Mark G., et al. "Efficacy, Safety, and Patient-Reported Outcomes in Patients With Moderate-to-Severe Plaque Psoriasis Treated With Brodalumab for 5 Years in a Long-Term, Open-Label, Phase II Study." Am J Clin Dermatol 2019.